Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nudix hydrolase 5 (NUDT5) is an enzyme in the Nudix hydrolase family, primarily acting as an ADP-sugar pyrophosphatase that hydrolyzes ADP-ribose and related ADP-sugar molecules to generate nuclear ATP, which is essential for rapid chromatin remodeling, hormone-induced gene regulation, and cell proliferation. NUDT5 also maintains the integrity of the nucleotide pool by sanitizing oxidized nucleotides (such as 8-oxo-dGDP), although its physiological role in oxidative nucleotide sanitation is less prominent compared to its major function in ADP-ribose metabolism. NUDT5 has emerged as a potential therapeutic target, particularly in hormone-driven cancers such as breast cancer, where inhibition suppresses hormone-dependent gene regulation and cell proliferation by disrupting nuclear ATP synthesis. Recent genetic studies highlight its role in modulating thiopurine response in leukemia, proposing it as a pharmacogenetic determinant in chemotherapy. The protein is characterized structurally by typical Nudix motifs essential for its catalytic activity, engaging Mg2+ ions and key residues to hydrolyze substrates. NUDT5’s multifaceted involvement in nuclear energy metabolism, transcriptional regulation, and drug response underscore its clinical and biological significance, while making it a complex target for both biomarker and drug development.
Inhibition of nuclear ATP synthesis via blockade of ADP-ribose hydrolysis (e.g., chromatin remodeling inhibition by compounds like TH5427 in cancer cells); Modulation of thiopurine response through alteration of purine metabolism and nucleotide pool.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nudix hydrolase 5 (NUDT5).